Next, we investigated that the effect of maritoclax on TRAIL-induced apoptosis in other renal carcinoma (ACHN and A498) and other type carcinoma (lung carcinoma A549 and hepatocellular carcinoma SK-Hep1). Here, TNFSF10 is linked to lung carcinoma.